IP Library Granted Patent US 8,523,813
Granted Patent B2
US 8,523,813 · App. 12/762,588 · Granted Sep 3, 2013

Injector auto purge

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,523,813
App. No.
12/762,588
Granted
Sep 3, 2013
Kind
B2
Abstract

An auto purge for an intravenous contrast injector of the type having a motor which advances a plunger drive ram and configured for use with a pre-filled or user-filled syringe containing an approximate known amount of air including a processor which causes the motor to move and a memory storing a predetermined purge stop point representative of the approximate known amount of air in the syringe, the injector configured to automatically advance the plunger drive ram an amount substantially equal to the predetermined purge stop point representative of the approximate known amount of air contained in the syringe.

Claims (32)

1. A medical fluid injector comprising:

a first syringe having:

a first barrel that includes a first discharge tip; and

a first plunger disposed within and movable relative to the first barrel;

a second syringe having:

a second barrel that includes a second discharge tip; and

a second plunger disposed within and movable relative to the second barrel;

a first plunger drive ram configured to move the first plunger of the first syringe within and relative to the first barrel of the first syringe both toward and away from the first discharge tip of the first syringe; and

a processor which controls movement of the first plunger drive ram, the processor being configured with a purge sequence designed to force air and/or gas from the first syringe via the first discharge tip prior to fluidly connecting the first syringe with a patient, the purge sequence comprising a set of instructions that is stored in memory, wherein the set of instructions for the purge sequence comprises instructions:

to move the first plunger drive ram toward a first predetermined stop point to in turn move the first plunger within the first barrel of the first syringe and toward the first discharge tip of the first syringe;

to stop the first plunger drive ram at the first predetermined stop point; and

to enable a first low flow rate upon the first plunger drive ram reaching and stopping at the first predetermined stop point, wherein the first low flow rate is a flow rate during which a first medical fluid is expelled from the first discharge tip of the first syringe due to the first plunger drive ram moving the first plunger within the first barrel of the first syringe, and wherein the first low flow rate is no more than about 1 ml/sec; and

wherein the processor being further configured with an injection protocol designed to inject medical fluid into a patient when the first syringe is fluidly connected with a patient.

2. The injector of claim 1 , wherein the first low flow rate is no more than about 0.5 ml/sec.

3. The injector of claim 1 , wherein the set of instructions for the purge sequence further comprises instructions to advance the first plunger drive ram to provide an initial flow rate until reaching the first predetermined stop point, wherein the initial flow rate is a flow rate at which the first medical fluid is expelled from the first discharge tip of the first syringe due to the first plunger drive ram moving the first plunger within the first barrel of the first syringe, and wherein the initial flow rate is greater than the first low flow rate.

4. The injector of claim 1 , wherein the first low flow rate is applicable to a manual movement control of the injector.

5. The injector of claim 1 , wherein the first low flow rate is applicable to an automatic purge from the first syringe until the automatic purge is stopped by operator input.

6. The injector of claim 1 , wherein the first medical fluid comprises contrast media.

7. The injector of claim 1 , wherein the second syringe contains saline.

8. The injector of claim 1 , wherein the first predetermined stop point is based on at least one parameter of the first syringe.

9. The injector of claim 1 , further comprising:

a second plunger drive ram configured to move the second plunger of the second syringe within and relative to the second barrel of the second syringe and toward the second discharge tip of the second syringe, the set of instructions for the purge sequence further comprising instructions:

to move the second plunger drive ram toward a second predetermined stop point to in turn move the second plunger within the second barrel of the second syringe and toward the second discharge tip of the second syringe prior to fluidly connecting the second syringe with the patient;

to stop the second plunger drive ram at the second predetermined stop point; and

to enable a second low flow rate upon the second plunger drive ram reaching and stopping at the second predetermined stop point, wherein the second low flow rate is a flow rate during which a second medical fluid is expelled from the second discharge tip of the second syringe due to the second plunger drive ram moving the second plunger within the second barrel of the second syringe, and wherein the second low flow rate is no more than about 1 ml/sec.

10. The injector of claim 9 , wherein the second low flow rate is no more than about 0.5 ml/sec.

11. The injector of claim 9 , wherein the first medical fluid comprises contrast media, and wherein the second medical fluid comprises saline.

12. The injector of claim 9 , wherein the set of instructions for the purge sequence further comprises instructions to move the second plunger drive ram to the second predetermined stop point some time after the first plunger drive ram has already been moved to the first predetermined stop point.

13. The injector of claim 12 , wherein the first medical fluid comprises contrast media, and wherein the second medical fluid comprises saline.

14. The injector of claim 9 , wherein movement of the first plunger drive ram to the first predetermined stop point is initiated in response to first user input, wherein movement of the second plunger drive ram to the second predetermined stop point is initiated in response to second user input, and wherein the second user input is provided after the first low flow rate has been enabled.

15. The injector of claim 14 , wherein the first medical fluid comprises contrast media, and wherein the second medical fluid comprises saline.

16. The injector of claim 9 , wherein the second predetermined stop point is based on at least one parameter of the second syringe.

Assignments (7)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2010
From: GRISPO, KEITH M.; FAGO, FRANK M.
To: LIEBEL-FLARSHEIM COMPANY
Reel/Frame 025379/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2010
From: LIEBEL-FLARSHEIM COMPANY
To: MALLINCKRODT INC.
Reel/Frame 025409/0901 →